18.02.2022
Acino and Ferrer sign distribution agreement
Acino will commercialize several Ferrer products in the fields of neurology, urology and treatment of respiratory disorders in the Republic...
Acino will commercialize several Ferrer products in the fields of neurology, urology and treatment of respiratory disorders in the Republic...
ZURICH, Switzerland, 22 October 2021 – Acino and Aspen Pharmacare Holdings Limited and its subsidiaries (collectively, “Aspen”) have signed an...
ADQ to acquire Acino, a Swiss-based pharmaceutical manufacturer with presence in more than 90 countries Investment builds on ADQ’s intent...
Pharmaceutical Group of Companies Acino (Switzerland) has signed an exclusive distribution agreement with Merz Therapeutics (Germany), a business of Merz...
Agreement between Swiss Acino and UAE-based EU GMP-licensed Pharmax covers the licensing, manufacturing, and supply of select Acino products across...
Zurich, Switzerland and Moscow, Russia, 1 April 2021 – Acino announced today the completion of the acquisition of select portfolio...
Acino has won the tender of the Ministry of Health of Ukraine (MOH) through the United Nations Development Program in...
Acino and Takeda Pharmaceuticals announced today the completion of the acquisition for parts of Takeda’s primary care portfolio in selected...
Acino Contract Manufacturing is pleased to announce a strategic partnership with UK-based Quay Pharma for the formulation and development of...